Back
Abbott Laboratories 10K Form
Sell
47
ABT
Abbott Laboratories
Last Price:
102.82
Seasonality Move:
3.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-05-05 | 10Q | ABT/Abbott Laboratories Quarterly |
2020-11-04 | 10Q | ABT/Abbott Laboratories Quarterly |
2020-07-29 | 10Q | ABT/Abbott Laboratories Quarterly |
2020-04-29 | 10Q | ABT/Abbott Laboratories Quarterly |
2020-02-21 | 10K | ABT/Abbott Laboratories Annual |
2019-10-31 | 10Q | ABT/Abbott Laboratories Quarterly |
Receive ABT News And Ratings
See the #1 stock for the next 7 days that we like better than ABT
ABT Financial Statistics
Sales & Book Value
Annual Sales: | $43.65B |
---|---|
Cash Flow: | $696M |
Price / Cash Flow: | 32.88 |
Annual Sales: | $21.42 |
Price / Book: | 4.8 |
Profitability
EPS (TTM): | 2.93000 |
---|---|
Net Income (TTM): | $5.16B |
Gross Margin: | $24.51B |
Return on Equity: | 14.1% |
Return on Assets: | 7% |
Abbott Laboratories Earnings Forecast
Key Abbott Laboratories Financial Ratios
- The Gross Profit Margin over the past 39 years for ABT is 56.15%.
- The Selling, General & Administrative Expenses for ABT have been equal to 25.77% of Gross Profit Margin.
- The Research & Development expenses have been 6.62% of Revenue.
- The Interest Expense is 8.05% of Operating Income.
- The Net Earning history of ABT is 15.88% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 29 years.
Abbott Laboratories Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Medical Devices |
Sector: | Healthcare |
Current Symbol: | ABT |
CUSIP: | 002824 |
Website: | abbottinvestor.com |
Debt
Debt-to-Equity Ratio: | 0.45 |
---|---|
Current Ratio: | 1.64 |
Quick Ratio: | 1.16 |
Price-to-Earnings
Trailing P/E Ratio: | 26.3 |
---|---|
Forward P/E Ratio: | 22.2 |
ABT Technical Analysis vs Fundamental Analysis
Sell
47
Abbott Laboratories (ABT)
is a Sell
Is Abbott Laboratories a Buy or a Sell?
-
Abbott Laboratories stock is rated a Sell
The current Abbott Laboratories [ABT] share price is $102.85. The Score for ABT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.